Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Renner

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuro-Oncology|July 13, 2010
Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastomaJuraj Hlavaty, Gerrit Jandl, Melissa Liszt, et al.
Cancer Immunology, Immunotherapy : CII|January 31, 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approachAngela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 28, 2016
Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy ProductsTakao Hayakawa, Ian Harris, Jeewon Joung, et al.
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 22, 2003
Intra-arterial instillation of microencapsulated, Ifosfamide-activating cells in the pig pancreas for chemotherapeutic targetingJens-Christian Kröger, Stefan Benz, Anne Hoffmeyer, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuro-Oncology|July 13, 2010
Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastomaJuraj Hlavaty, Gerrit Jandl, Melissa Liszt, et al.
Cancer Immunology, Immunotherapy : CII|January 31, 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approachAngela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 28, 2016
Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy ProductsTakao Hayakawa, Ian Harris, Jeewon Joung, et al.
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 22, 2003
Intra-arterial instillation of microencapsulated, Ifosfamide-activating cells in the pig pancreas for chemotherapeutic targetingJens-Christian Kröger, Stefan Benz, Anne Hoffmeyer, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Pageof 4